T45.1X5A - Adverse effect of antineoplastic and immunosup drugs, init

The ICD 10 Code for Adverse effect of antineoplastic and immunosup drugs, init is listed as T45.1X5A.
Additional information concerning this code and description can be found below including ICD 9 crosswalks / GEMS, chapter information, and DRGs where available.

ICD 10 CM Field	Value
Diagnosis Code:	T45.1X5A
Description:	Adverse effect of antineoplastic and immunosup drugs, init
Diagnostic Related Groups (MS-DRG v30.0)	793 - Full Term Neonate W Major Problems 917 - Poisoning & Toxic Effects Of Drugs W Mcc 918 - Poisoning & Toxic Effects Of Drugs W/o Mcc

Chapter	Injury, poisoning and certain other consequences of external causes (S00-T88)
Block	Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)
Parent	T45.1X5 - Adverse effect of antineoplastic and immunosuppressive drugs
ICD-9-CM Diagnosis Codes General Equivalence Mappings (GEMS):
ICD 9 Dx Code:	Combination: 995.29 - Unspecified adverse effect of other drug, medicinal and biological substance with E933.1 - Antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use
ICD-10-CM Siblings (same level / similar specificity) of T45.1X5A:
T45.1X5D - Adverse effect of antineoplastic and immunosup drugs, subs
T45.1X5S - Adverse effect of antineopl and immunosup drugs, sequela